XML 113 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net loss $ (323,916) $ (514,706) $ (126,820)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 24,896 33,112 31,145
Loss on abandonment and disposals of assets, net 3,071 20,928 3,124
Impairment loss 120,489 60,504 16,773
Reacquisition of in-process research and development 0 236,748 0
Unrealized and realized (appreciation) depreciation on equity securities and preferred stock, net (7,833) 30,200 (2,586)
Noncash dividend income (48) (14,841) (16,756)
Amortization of premiums (discounts) on investments, net (1,005) (771) 411
Equity in net loss of affiliates 6,730 11,608 14,283
Stock-based compensation expense 18,950 36,296 41,576
Shares issued as payment for services 10,446 10,695 11,118
Provision for bad debts 3,242 1,779 1,217
Accretion of debt discount and amortization of deferred financing costs 9,459 4,378 0
Deferred income taxes (3,674) (21,278) (2,528)
Other noncash items 837 1,093 (517)
Receivables:      
Trade (262) (2,698) 740
Related parties 967 11,003 631
Other (656) (542) 661
Inventory 4,100 (478) 663
Prepaid expenses and other (2,262) 1,006 492
Other assets 333 652 (1,017)
Accounts payable (5,349) 4,680 (3,402)
Accrued compensation and benefits 5,186 4,385 (1,466)
Other accrued liabilities (5,516) 356 3,007
Deferred revenue 7,423 (38,578) (75,337)
Deferred consideration 0 0 (313)
Lease liabilities (995)    
Related party payables 45 (52) (147)
Other long-term liabilities (585) 281 1,328
Net cash used in operating activities (135,927) (124,240) (103,720)
Cash flows from investing activities      
Purchases of investments (55,073) (178,681) 0
Sales and maturities of investments 166,495 65,975 174,542
Purchases of preferred stock and warrants 0 0 (1,161)
Proceeds from sales of equity securities 23,456 217 235
Acquisitions of businesses, net of cash received 0 (920) 2,054
Investments in affiliates (3,713) (16,582) (11,189)
Decrease in cash from deconsolidation of subsidiary (7,244) 0 0
Return of investment in affiliate 125 2,598 0
Cash received (paid) in asset acquisitions 0 15,500 (14,219)
Purchases of property, plant and equipment (37,883) (41,587) (46,666)
Proceeds from sale of assets 688 2,267 1,636
Issuances of notes receivable 0 0 (2,400)
Proceeds from repayment of notes receivable 0 0 1,500
Net cash provided by (used in) investing activities 86,851 (151,213) 104,332
Cash flows from financing activities      
Proceeds from issuance of shares in a private placement 0 0 13,686
Proceeds from issuance of shares and warrants in public offerings, net of issuance costs 6,611 87,990 0
Acquisitions of noncontrolling interests 0 0 (913)
Advances from lines of credit 11,757 4,561 5,906
Repayments of advances from lines of credit (10,301) (4,328) (6,493)
Proceeds from long-term debt, net of issuance costs 376 219,859 325
Payments of long-term debt (618) (623) (519)
Payments of deferred consideration for acquisitions 0 0 (8,678)
Proceeds from stock option and warrant exercises 313 2,336 980
Payment of stock issuance costs 0 0 (10)
Net cash provided by financing activities 8,138 309,795 4,284
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (810) 295 1,055
Net increase (decrease) in cash, cash equivalents, and restricted cash (41,748) 34,637 5,951
Cash, cash equivalents, and restricted cash      
Beginning of year 110,182 75,545 69,594
End of year 68,434 110,182 75,545
Supplemental disclosure of cash flow information      
Cash paid during the period for interest 3,751 3,868 617
Cash paid during the period for income taxes 50 216 566
Significant noncash activities      
Stock received as consideration for collaboration agreements 4,530 0 0
Receivables converted to preferred stock 0 0 3,385
Stock and warrants issued in business combinations 0 0 16,997
Stock issued to acquire noncontrolling interests 0 0 5,082
Stock issued for reacquired in-process research and development 0 159,323 0
Long-term debt issued to a related party in an asset acquisition 0 30,000 0
Noncash dividend to shareholders 0 0 22,385
Purchases of property and equipment included in accounts payable and other accrued liabilities 694 2,267 2,257
Purchases of equipment financed through debt 0 234 0
Receivable recorded in anticipation of dissolution of affiliate $ 0 $ 0 $ 2,598